Medicine. The need for a global HIV vaccine enterprise.
Richard D Klausner;
Anthony S Fauci;
Lawrence Corey;
Gary J Nabel;
Helene Gayle;
Seth Berkley;
Barton F Haynes;
David Baltimore;
Chris Collins;
R Gordon Douglas;
+14 more...
Jose Esparza;
Donald P Francis;
NK Ganguly;
Julie Louise Gerberding;
Margaret I Johnston;
Michel D Kazatchkine;
Andrew J McMichael;
Malegapuru W Makgoba;
Giuseppe Pantaleo;
Peter Piot;
Yiming Shao;
Edmund Tramont;
Harold Varmus;
Judith N Wasserheit;
(2003)
Medicine. The need for a global HIV vaccine enterprise.
Science (New York, NY), 300 (5628).
pp. 2036-2039.
ISSN 0036-8075
DOI: 10.1126/science.1086916
A new collaborative model of research is needed to increase resources, to prioritize the R (ii) to increase the pace, reduce the overlap, and more systematically explore the elements of and delivery systems for vaccines; (iii) to use common standards for the prompt comparative testing of vaccine candidates; (iv) to expand resources for manufacturing vaccine candidates to speed their use in human trials; and (v) to increase the capacity for international clinical trials and to focus this effort toward quickly measuring the effectiveness of vaccine protection as prototype vaccine candidates are identified.
| Item Type | Article |
|---|---|
| Keywords | *AIDS Vaccines/administration & dosage/economics/immunology, Academies and Institutes/economics/organization & administration, Biotechnology/economics, Clinical Trials as Topic/standards, Drug Design, Drug Evaluation, Preclinical/standards, Drug Industry/economics, Financial Support, HIV Infections/*prevention & control, HIV-1/*immunology, Humans, Intellectual Property, International Cooperation, Multicenter Studies as Topic, Private Sector, *Public Policy, Public Sector, Research Support as Topic, Vaccination, *World Health, AIDS Vaccines, administration & dosage, economics, immunology, Academies and Institutes, economics, organization & administration, Biotechnology, economics, Clinical Trials as Topic, standards, Drug Design, Drug Evaluation, Preclinical, standards, Drug Industry, economics, Financial Support, HIV Infections, prevention & control, HIV-1, immunology, Humans, Intellectual Property, International Cooperation, Multicenter Studies as Topic, Private Sector, Public Policy, Public Sector, Research Support as Topic, Vaccination, World Health |
| ISI | 183774900028 |